Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-10T06:19:41.912Z Has data issue: false hasContentIssue false

7 - Tuberculosis

Published online by Cambridge University Press:  18 August 2009

Anthony R. M. Coates
Affiliation:
St George's Hospital Medical School, University of London
Get access

Summary

INTRODUCTION

Tuberculosis (TB) is the single most important infectious disease in the world. This disease is caused by Mycobacterium tuberculosis. Although tuberculosis can be cured by antimicrobial therapy and can be prevented by a vaccine [Bacille Calmette-Guerin (BCG)], the total number of cases in the world is still increasing (52). There are 8 millions new cases every year, and over 3 million TB patients will die of this disease (33). After infection, which usually takes place in childhood, the bacteria are capable of persisting in a non-replicating or quiescent state for prolonged periods of time (73). These quiescent bacteria are called “immune persisters” by the authors, because they are induced by, and survive, the immune response (73). Reactivation of persisters, sometimes many years later, is responsible for most cases of active disease (59, 73). About one third of the world's population, two billion people, contain quiescent M. tuberculosis (60) and so this is by far the most common form of the microbe. These carriers provide a huge pool of potential disease, the lifetime risk of a carrier developing active tuberculosis being 5–10% (18). It is not known why many carriers break down into disease, but in some, weakening of the immune system, for example, by co-infection with HIV, is strongly associated with tuberculosis (18).

The main disease-control measures used for tuberculosis are casefinding and chemotherapy (3). However, chemotherapy itself induces persisters which are called “drug persisters” by the authors (30).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×